Impaired lymphocyte reactivity measured by immune function testing in untransplanted patients with cirrhosis

Clinical and Vaccine Immunology

Volumn 20, Issue 4, 2013, Pages 526-529

  Yee, Russell M ^a   Lehil, Mandeep S ^b   Rongey, Catherine ^b   Shen, Hui ^b   Cozen, Myrna L ^b   Monto, Alexander ^b   Ryan, James C ^b,c  

^a Columbia University ^*  (United States)

^b Departments of Medicine   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL METABOLISM; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNE FUNCTION TEST; IMPAIRED LYMPHOCYTE REACTIVITY; LIVER CIRRHOSIS; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNE TOLERANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84876479023     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00595-12     Document Type: Article

References (19)

1. Sottong PR, Rosebrock JA, Britz JA, Kramer TR. 2000. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clin. Diagn. Lab. Immunol. 7:307-311.
2. Cadillo-Chavez R, de Echegaray S, Santiago-Delpin EA, Rodriguez-Trinidad AT, Camacho-Carrazo B, Alfaro T, Saavedra-Pozo M, Carrasquillo L, Gonzalez-Caraballo ZA, Morales-Otero LA. 2006. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant. Proc. 38:918-920.
3. Alter HJ, Seeff LB. 2000. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Semin. Liver Dis. 20:17-35.
4. Neumann UP, Berg T, Bahra M, Seehofer D, Langrehr JM, Neuhaus R, Radke C, Neuhaus P. 2004. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J. Hepatol. 41:830-836.
5. Demetris AJ. 2009. Evolution of hepatitis C virus in liver allografts. Liver Transpl. 15(Suppl. 2):S35-S41.
6. Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P. 2004. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation 77:226-231.
7. Alkhouri N, Hanouneh IA, Lopez R, Zein NN. 2010. Monitoring peripheral blood CD4? adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression. Liver Transpl. 16:155-162.
8. Mendler M, Kwok H, Franco E, Baron P, Weissman J, Ojogho O. 2008. Monitoring peripheral blood CD4? adenosine triphosphate activity in a liver transplant cohort: Insight into the interplay between hepatitis C virus infection and cellular immunity. Liver Transpl. 14:1313-1322.
9. Gale M, Jr, Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436:939-945.
10. Rajkovic IA, Williams R. 1986. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6:252-262.
11. Bruce-Chwatt LJ. 1965. Declaration of Helsinki. Recommendations guiding doctors in clinical research. WHO Chron. 19:31-32.
12. Whaley K, Schwaeble W. 1997. Complement and complement deficiencies. Semin. Liver Dis. 17:297-310.
13. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. 2002. Bacterial infections in cirrhosis: Epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35:140-148.
14. Bonacini M, Govindarajan S, Kohla M, Lai MM, Lindsay KL. 2007. Intrahepatic lymphocyte phenotypes in hepatitis C virus infection: A comparison between cirrhotic and non-cirrhotic livers. Minerva Gastroenterol. Dietol. 53:1-7.
15. Winau F, Hegasy G, Weiskirchen R, Weber S, Cassan C, Sieling PA, Modlin RL, Liblau RS, Gressner AM, Kaufmann SH. 2007. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26:117-129.
16. Friedman SL. 2010. Evolving challenges in hepatic fibrosis. Nat. Rev. Gastroenterol. Hepatol 7:425-436.
17. Winau F, Quack C, Darmoise A, Kaufmann SH. 2008. Starring stellate cells in liver immunology. Curr. Opin. Immunol. 20:68-74.
18. Yoshizawa, K., H. Abe, Y. Kubo, T. Kitahara, R. Aizawa, M. Matsuoka, Y. Aizawa. 2010. Expansion of CD4(?)CD25(?)FoxP3(?) regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma. Hepatol. Res. 40:179-187.
19. Bloom RD, Lake Jr. 2006. Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients. Am. J. Transplant. 6:2232-2237.